Business2 outlets
Mazumdar-Shaw's Mission to Expand Access to Life-Saving Drugs
Kiran Mazumdar-Shaw, founder of Biocon and a prominent figure in India's biotechnology industry, has built the company into a multibillion-dollar global manufacturer of insulin and biosimilar drugs. Known as India's 'Queen of Biotech', Mazumdar-Shaw established Biocon from modest beginnings and has positioned it as one of the world's largest producers in its sector. As she transitions leadership responsibilities, she is reflecting on her mission to expand access to life-saving medications.
Key takeaways
- 1.Biocon has grown into a multibillion-dollar company and a global leader in insulin and biosimilar drug production
- 2.Mazumdar-Shaw founded the company from modest beginnings and is recognized as a prominent figure in Indian biotechnology
- 3.Leadership transition is occurring at Biocon as Mazumdar-Shaw prepares to hand over responsibilities to successors
Outlet bias
Based on Trace's curated lean for each newsroom. Scroll to coverage below to rate any outlet Left / Center / Right yourself.
Left 0% · 0Center 100% · 2